Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 19, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish...
-
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 19, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish...
-
Company Announcement Genmab signs agreement with Janssen Biotech, Inc. to collaborate exclusively on next-generation CD38 antibody product, HexaBody®-CD38, incorporating Genmab’s proprietary HexaBody...
-
Company Announcement Copenhagen, Denmark; June 6, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 6,464 restricted stock units and 21,343...
-
Company Announcement U.S. FDA grants Priority Review for daratumumab in combination with bortezomib, thalidomide and dexamethasone as treatment for newly diagnosed patients with multiple myeloma...
-
Company Announcement Genmab has today filed a registration statement with the U.S. Securities and Exchange Commission for the proposed public offering of ADSs and has applied for listing of the ADSs...
-
Media Release Copenhagen, Denmark, May 16, 2019 15 industry-sponsored abstracts featuring Genmab programs selected for presentation at EHA Annual Congress Genmab A/S (Nasdaq Copenhagen: GEN)...
-
Company Announcement Copenhagen, Denmark; May 14, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 9,737 shares as a consequence of the exercise of employee warrants. ...
-
May 8, 2019; Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2019 Highlights Regulatory applications for daratumumab in combination with lenalidomide and dexamethasone...
-
Media Release Copenhagen, Denmark, April 17, 2019 14 industry sponsored abstracts regarding Genmab programs selected for presentation at ASCO Annual Meeting Genmab A/S (Nasdaq Copenhagen: GEN)...